Michigan Moves from Motors to Molecules

Michigan can call to mind images of the Great Lakes or of canoe trips through freshwater marshes. The city of Detroit may evoke the clanging of a car-part conveyor belt or the odor from smokestacks. But now Michigan officials and entrepreneurs also want investors around the world to envision hubs of high-tech collaborations that will transform the state into a biotechnology hotspot within the decade. Surprising to many, Michigan already has built a vigorous life science community. The state boas

Written byTed Agres
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Surprising to many, Michigan already has built a vigorous life science community. The state boasts more than 300 biotech companies, a handful of pharmaceutical giants, and a triad of world-class research universities. This lineup helped create 16,800 life science jobs in 2000, making the state the 11th largest supplier of such positions in the United States, according to the Michigan Economic Development Corp. (MEDC). The workers generate $1.6 billion (US) in sales, placing the state 10th among those that produce life-science revenues. Michigan also compares favorably to the new biotechnology clusters in Britain, Sweden, and Germany.

The total number of biotechnology companies nearly matches those found in the region surrounding the National Institutes of Health in Maryland, but Michigan officials concede the state cannot boast of a large concentration of these companies, as can Boston, San Francisco, Metropolitan Washington D.C., or Research Triangle Park, N.C. The state also lacks sufficient ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies